Seeking Alpha

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best ...
Seeking Alpha

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the ...
Yahoo Finance

Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation

MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced the appointment of Kelly Johnston McKee as Vice President, ...
Nasdaq

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
Business Insider

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading Metasite TM, today announced the launch of a stand-alone Patient ...
FierceBiotech

Science 37 tapped for Synlogic's phase 3 trial of potential PKU treatment

Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
Nasdaq

Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities

RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, announced today that it has acquired the life sciences platform ...
Business Wire

Science 37 and AOBiome Complete Industry-First Virtual Clinical Trial Through Metasite™ (Decentralized) Operating Model

PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...
Business Insider

Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership

MORRISVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced that it has been awarded the Research and Development – Site ...

Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes

Science 37 is a leading patient access company in clinical research that delivers trials directly to patients' homes.
FOX40 News

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

“After an extensive review of opportunities available to Science 37, we believe that eMed provides the greatest value to our stockholders, customers, patients, and employees” said David Coman, Chief ...